Russell Investments Group
LXEO icon

Russell Investments Group’s Lexeo Therapeutics LXEO Stock Holding History

Russell Investments Group’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Buy
33,273
+26,634
+401% +$144K ﹤0.01% 3283
2026
Q1 		$38.1K Buy
6,639
+767
+13% +$5.43K ﹤0.01% 3411
2025
Q4 		$58.3K Buy
5,872
+3,615
+160% +$33K ﹤0.01% 3247
2025
Q3 		$15K Buy
2,257
+2,038
+931% +$9.86K ﹤0.01% 3680
2025
Q2 		$880 Buy
+219
New +$720 ﹤0.01% 3683
2025
Q1 		– Sell
-416
Closed -$2.74K – 3846
2024
Q4 		$2.74K Buy
+416
New +$3.28K ﹤0.01% 3388

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Russell Investments Group's LXEO Position: Q2 2026 in Review

Russell Investments Group increased its Lexeo Therapeutics (LXEO) stake by 401% in Q2 2026, buying an estimated $144K and bringing the position to 33,273 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #3283.

Russell Investments Group first reported a position in LXEO in Q4 2024 and has held it in 6 quarters since. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Russell Investments Group held 33,273 shares of Lexeo Therapeutics worth $155K as of Q2 2026.
  • Russell Investments Group bought 26,634 Lexeo Therapeutics shares in Q2 2026, an estimated $144K.
  • Lexeo Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3283 holding.
  • Russell Investments Group first reported a position in Lexeo Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.